SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Sanofi’s Infilbray Approved in US for Type 3 Gaucher Disease

The medicine was approved in the US as the first treatment for neurological manifestations of Type 3 Gaucher disease.

Related stories